IP Library Granted Patent US 10,299,472
Granted Patent B2
US 10,299,472 · App. 15/460,880 · Granted May 28, 2019

Coating material

Inventors: Michael Wagener (Bremen, DE); Klaus Dieter Vissing (Morsum, DE); Dirk Salz (Bremen, DE); Peter Steinrücke (Erlangen, DE)
Assignees: BIO-GATE AG; FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
A01N25/34A01N25/10A01N59/16A01N59/20A61L15/18A61L15/26A61L15/44A61L27/306A61L27/34A61L27/54A61L29/085A61L29/106A61L29/16A61L31/088A61L31/10A61L31/16A61L2300/102A61L2300/104A61L2300/404A61L2420/02A61L2420/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,299,472
App. No.
15/460,880
Granted
May 28, 2019
Kind
B2
Abstract

The invention relates to an antimicrobial and preferably non-cytotoxic coating material and to use of said coating material.

Claims (38)

1. A device having an antimicrobial and non-cytotoxic coating, comprising:

a) a substrate comprising a surface, wherein:

(i) the substrate comprises a material selected from the group consisting of metal and plastic,

(ii) the substrate has a form selected from the group consisting of particles and fibers, or

(iii) both option (i) and option (ii);

b) a biocide layer covering the surface, said biocide layer having a biocidal active agent in the form of single particles, chains of particles, or both, and

c) a transport control layer covering the biocide layer, having a thickness and porosity adjusted to release an antimicrobial and non-cytotoxic quantity of the biocidal active agent out of the biocide layer and through the transport control layer,

wherein the transport control layer is a plasma polymer layer and/or a sputter-applied layer and wherein the transport control layer has a silicon content of 20 to 60%, a carbon content between 10 and 30% and an oxygen content of 30 to 50%, wherein the transport control layer is hydrophilic, wherein the particles of the single particles or chains of particles have a mean particle size of 5-100 nm.

2. The device of claim 1 , wherein said device is selected from the group consisting of an implant, a bone fixation screw, and a dental implant.

3. The device of claim 1 , wherein the substrate comprises a material selected from the group consisting of metal and plastic.

4. The device of claim 1 , wherein the substrate has a form selected from the group consisting of particles and fibers.

5. The device of claim 1 , wherein the transport control layer has a gas permeability for oxygen (O 2 ) which is in the range from 100 to 1000 (cm 3 bar)/(day m 2 ).

6. The device of claim 1 , wherein the transport control layer has a gas permeability for oxygen (O 2 ) which is in the range from 500 to 700 (cm 3 bar)/(day m 2 ).

7. The device of claim 1 , wherein the biocidal active agent is selected from the group consisting of silver, copper and zinc, their ions and their metal complexes, or a mixture or alloy comprising two or more of said elements.

8. The device of claim 7 , wherein the biocide layer further comprises: gold, platinum, palladium, iridium, tin, antimony, their ions, their metal complexes, or an alloy of the biocidal active agent with one or more of said elements.

9. The device of claim 1 , wherein the coating comprises a substrate material that is selected from the group consisting of

a) an organic substrate material, selected from the group consisting of a plasma polymer, a sol-gel, a coating, and a siliconised substrate material,

b) an inorganic substrate material, selected from the group consisting of SiO 2 and SiC, a metal oxide and a non-biocidal metal, and

c) a combination thereof.

10. The device of claim 9 , wherein the metal oxide is TiO 2 , Al 2 O 3 or a combination thereof, and wherein the non-biocidal metal is titanium, medical stainless steel, or a combination thereof.

11. The device of claim 1 , wherein the transport control layer has a mean thickness of 5-500 nm.

12. The device of claim 1 , wherein said device is selected from the group consisting of a catheter, a wound covering, an implant, a medical nail, a medical screw, a bone fixation nail, a dental implant, a medical instrument, and a sanitary product.

13. The device of claim 1 , wherein the biocidal active agent comprises an agent selected from the group consisting of silver, silver ions, and silver complexes.

14. A device having an antimicrobial and non-cytotoxic coating, comprising:

a) a substrate comprising a surface, wherein:

(i) the substrate comprises a material selected from the group consisting of metal and plastic,

(ii) the substrate has a form selected from the group consisting of particles and fibers, or

(iii) both option (i) and option (ii);

b) a biocide layer covering the surface, said biocide layer having a biocidal active agent in the form of single particles, chains of particles, or both, and

c) a transport control layer covering the biocide layer, having a thickness and porosity adjusted to release an antimicrobial and non-cytotoxic quantity of the biocidal active agent out of the biocide layer and through the transport control layer,

wherein the transport control layer contacts the biocide layer,

wherein the transport control layer is a plasma polymer layer and/or a sputter-applied layer and wherein the transport control layer has a silicon content of 20 to 60%, a carbon content between 10 and 30% and an oxygen content of 30 to 50%, wherein the transport control layer is hydrophilic, wherein the particles of the single particles or chains of single particles have a mean particle size of 5-100 nm.

15. The device of claim 14 , wherein said device is selected from the group consisting of an implant, a bone fixation screw, and a dental implant.

16. The device of claim 14 , wherein the substrate comprises a material selected from the group consisting of metal and plastic.

17. The device of claim 14 , wherein the substrate has a form selected from the group consisting of particles and fibers.

18. The device of claim 14 , wherein said device is selected from the group consisting of a catheter, a wound covering, an implant, a medical nail, a medical screw, a bone fixation nail, a dental implant, a medical instrument, and a sanitary product.

19. The device of claim 14 , wherein the biocidal active agent comprises an agent selected from the group consisting of silver, silver ions, and silver complexes.

20. The device of claim 1 , wherein the substrate comprises plastic.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2019
From: WAGENER, MICHAEL; STEINRUCKE, PETER
To: BIO-GATE BIOINNOVATIVE MATERIALS GMBH
Reel/Frame 048403/0384 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2019
From: VISSING, KLAUS DIETER; SALZ, DIRK
To: FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
Reel/Frame 048403/0410 →
MERGER AND CHANGE OF NAME Recorded Feb 22, 2019
From: BIO-GATE BIOINNOVATIVE MATERIALS GMBH; NANO-SILBER-AG
To: BIO-GATE AG
Reel/Frame 048421/0081 →
Priority Claims (1)
DE 103 53 756 · Nov 17, 2003 · national
Continuity (2)
Division 10580300
Related Publication 20170181428A1 · Jun 29, 2017